SPAG5 as a Prognostic Biomarker and Chemotherapy Sensitivity Predictor in Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SPAG5 as a Prognostic Biomarker and Chemotherapy Sensitivity Predictor in Breast Cancer: A Retrospective, Integrated Genomic, Transcriptomic, and Protein Analysis
Lancet Oncol 2016 Jun 13;[EPub Ahead of Print], TM Abdel-Fatah, D Agarwal, DX Liu, R Russell, OM Rueda, K Liu, B Xu, PM Moseley, AR Green, AG Pockley, RC Rees, C Caldas, IO Ellis, GR Ball, SY ChanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.